Status:
UNKNOWN
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Lead Sponsor:
Liz-Anne Lewsley
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
RATIONALE: Studying tissue and blood samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may a...
Detailed Description
OBJECTIVES: * To determine if DNA methylation patterns and expression of differentially methylated genes taken before chemotherapy can predict patient outcome with regard to progression-free survival...
Eligibility Criteria
Inclusion
- Clinically suspected FIGO stages Ic-IV epithelial ovarian cancer that are about to undergo surgery for confirmatory biopsy and attempted cytoreductive surgery
- Given written informed consent
- Female and \>18 years of age
Exclusion
Key Trial Info
Start Date :
March 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00900289
Start Date
March 1 2002
Last Update
February 13 2013
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
Basildon University Hospital
Basildon, England, United Kingdom, SS16 5NL
2
St. Michael's Hospital
Bristol, England, United Kingdom, BS2 8EG
3
Queens Hospital
Burton-on-Trent, England, United Kingdom, DE13 0RB
4
Gloucestershire Oncology Centre at Cheltenham General Hospital
Cheltenham, England, United Kingdom, GL53 7AN